Professor of Obstetrics and Gynecology, Rush Medical College
Obstetrics & Gynecology
Dr. Jacob Rotmensch, MD
|
|
Give Review
Jacob Rotmensch is an expert in the field of Obstetrics & Gynecology. He researched medicine at Meharry Medical College. He received 7 awards: "America's Top Doctors", "Chicago Magazine: Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Chicago Magazine - Women's Health", "Top MD" and "Fellow (FACOG)". Jacob Rotmensch is a published doctor as well. He has 39 publications published. The latest was: A Delay from Diagnosis to Treatment Is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer. Jacob Rotmensch, MD accepts all Medicare patients.
Publications
- A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: An NRG Oncology/Gynecologic On...
- A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study.
- Use of Cervical mucus to screen for gynecological malignancies: a pilot study.
- Immunohistochemical Characterization of Squamous Differentiation and Morular Metaplasia in Uterine Endometrioid AdenoCarcinoma.
- Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial Carcinoma: A Gynecologic Oncology Group study.
- A Delay from Diagnosis to Treatment Is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer.
- Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian Cancer.
- Structural and mechanical profiles of native collagen fibers in vaginal wall connective tissues.
- Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian Cancer cells.
- Phase II trial of bevacizumab in recurrent or persistent endometrial Cancer: a Gynecologic Oncology Group study.
- A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal Cancer: a Gynecol...
- Optimal surgical debulking in uterine papillary serous Carcinoma affects survival.
- A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial Carcinoma: a gynecologic oncology group study.
- Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal Cancer after up to three prior regimens: a phase II study of the Gy...
- Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant Ovarian tumors.
- Helical Tomotherapy Delivery of an IMRT Boost in Lieu of Interstitial Brachytherapy in the Setting of Gynecologic Malignancy: Feasibility and Dosimetric Comparison.
- A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal Cancer: a gynecologic oncology gr...
- Quality of life of patients with endometrial Cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a G...
- A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal Cancer: a Gynecologic Oncology Group study.
- Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian Cancer.
- A dosimetric comparison of Xoft Axxent Electronic Brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial Cancer.
- Anti-tumor and anti-ovarian autoantibodies in women with ovarian Cancer.
- Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
- Changes in the sonographic appearance of the uterus after discontinuation of tamoxifen therapy.
- Anti-tumor antibodies in ovarian Cancer.
- Clitoral therapy device for treatment of sexual dysfunction in irradiated Cervical cancer patients.
- Rectovaginal radiation Fistula repair using an obturator fasciocutaneous thigh flap.
- Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical Carcinoma and other advanced pelvic malignancies.
- Outcome and pattern of failure in pathologic stage I-II papillary serous Carcinoma of the endometrium: implications for adjuvant radiation therapy.
- Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole Pelvic radiotherapy.
- Binary methods for the microdosimetric analysis of Cell survival data from alpha-particle irradiation.
- Characterization of an alpha-particle irradiator for individual Cell dosimetry measurements.
- Image processing tools for alpha-particle track-etch dosimetry.
- Outcome and patterns of failure in pathologic stages I-IV clear-cell Carcinoma of the endometrium: implications for adjuvant radiation therapy.
- Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
- Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced Uterine leiomyosarcoma: a Gynecologic Oncology Group study.
- Intensity-modulated whole Pelvic radiotherapy in women with gynecologic malignancies.
- An alpha-fetoprotein-producing hepatoid adenoCarcinoma of the endometrium.
Schools
Meharry Medical College
Johns Hopkins
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- Dilation and Curettage
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- Chicago Magazine: Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Chicago Magazine - Women's Health
- Top MD
- Fellow (FACOG)
Education
-
Johns Hopkins University -
Meharry Medical College
Hospital
-
Little Company of Mary Hospital and Health Care Centers -
Rush University Medical Center -
Swedish Covenant Hospital -
Mercy Hospital and Medical Center
Drug Facts
| NPI NUMBER | 1790746600 | |
| NPPES Provider LastName | ROTMENSCH | |
| NPPES Provider FirstName | JACOB | |
| NPPES Provider ZIPCode | 606123841 | |
| NPPES Provider State | IL | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 293.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 38.0 | |
| Percent Opioid Claims | 12.97 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790746600 |
| Last Name Of The Provider | ROTMENSCH |
| First Name Of The Provider | JACOB |
| View All |
Similar Doctors
|
Dr. Alfred S. Guirguis, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley E. Friedell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morteza Dini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prema B. Malani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Radha Malapati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diljeet K. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo Boler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. S D. Yamada, MD |
|
|
Dr. Emily N. Prendergast, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antea C. Singleton, MD
This Doctor is OpenDoctor Recommended.
|